Insider · CIK 0001841519
Catherine Carraway
officer
Files at VMRK (EQUITY RESIDENTIAL). First filing Feb 7, 2025, latest May 5, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $132k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
VMRK: EQUITY RESIDENTIAL
VMRKOct 9, 2026 · close 61.16
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 33Weak | VMRKsell EQUITY RESIDENTIAL | $71k 1,007 shares | -7% | +14% from low-7% from high | |
| 47Moderate | EQUITY RESIDENTIAL | $61k 845 shares | -6% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 1, 2025 | VMRK EQUITY RESIDENTIAL | SOpen-market sale Common Shares Of Beneficial Interest | -1,007 | $70.55 | $71k | 12,746 | May 5, 2025 |
| Feb 5, 2025 | VMRK EQUITY RESIDENTIAL | AGrant or award Common Shares Of Beneficial Interest | +3,943 | $0.00 | $0 | 14,598 | Feb 7, 2025 |
| Feb 6, 2025 | VMRK EQUITY RESIDENTIAL | SOpen-market sale Common Shares Of Beneficial Interest | -483 | $72.06 | $35k | 14,115 | Feb 7, 2025 |
| Feb 6, 2025 | VMRK EQUITY RESIDENTIAL | SOpen-market sale Common Shares Of Beneficial Interest | -362 | $72.06 | $26k | 13,753 | Feb 7, 2025 |
| Jan 17, 2025 | VMRK EQUITY RESIDENTIAL | AGrant or award Common Shares Of Beneficial Interest | +2,185 | $0.00 | $0 | 12,564 | Jan 22, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.